Chargement en cours...
Current status of bevacizumab in advanced ovarian cancer
Ovarian cancer is the most lethal gynecological cancer, mainly because of the delay in diagnosis. Recently, much effort has been put into investigating and introducing novel targeted agents into clinical practice, with the aim of improving prognosis and quality of life. Angiogenesis is a possible ta...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3724566/ https://ncbi.nlm.nih.gov/pubmed/23901283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S46301 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|